Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-20-019032
Filing Date
2020-06-05
Accepted
2020-06-05 17:23:30
Documents
1
Period of Report
2020-06-03

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 2772
  Complete submission text file 0001127602-20-019032.txt   4418
Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Issuer) CIK: 0000875045 (see all company filings)

EIN.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address IMCLONE SYSTEMS INCORPORATED 180 VARICK STREET, 6TH FLOOR NEW YORK NY 10014
Business Address
Rowinsky Eric K (Reporting) CIK: 0001318886 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19311 | Film No.: 20947383